Chen Bihua — SEC insider filings

SEC reporting owner CIK 1599214. 73 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers the 50 most recent of 73 filings on record, filed 2022-06-24 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MoonLake Immunotherapeutics (MLTX)—636 legs · 2,429,151 sh · $97,634,4985 legs · 6,499,978 sh · $46,868,184—
Ambrx Biopharma Inc. (AMAM)10% owner411 legs · 10,965,823 sh · $114,106,979——
EyePoint, Inc. (EYPT)—624 legs · 4,794,057 sh · $89,496,4131 leg · 60,000 sh · $942,240—
Corbus Pharmaceuticals Holdings, Inc. (CRBP)—631 legs · 1,932,632 sh · $53,693,2612 legs · 455,029 sh · $2,086,767—
BridgeBio Oncology Therapeutics, Inc. (BBOT)Director, 10% owner53 legs · 2,400,000 sh · $24,000,000—17
BRIGHT MINDS BIOSCIENCES INC. (DRUG)—312 legs · 606,922 sh · $7,234,3701 leg · 109,331 sh · $9,785,124—
Biomea Fusion, Inc. (BMEA)—61 leg · 400,000 sh · $12,000,000—4
Ambrx Biopharma, Inc. (AMAM)10% owner11 leg · 1,307,311 sh · $9,139,542——
BioAge Labs, Inc. (BIOA)—11 leg · 450,000 sh · $8,100,000—2
Helix Acquisition Corp. III (HLXC)Chairperson and CEO, Director, 10% owner21 leg · 800,000 sh · $8,000,000—4

+6 more issuers among the filings shown — every filing appears in the table below.

Insider filings — Chen Bihua

FiledFormIssuerReported transactionsSource
2026-11-024Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Sale (S): 425,000 @ $4.10EDGAR
2026-08-104BlossomHill Therapeutics, Inc. (BLSM)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Fund VI, LP
Conversion (C): 1,599,993 · Conversion (C): 1,701,541 · Purchase (P): 312,500 @ $16 · Grant/award (A): 23,904 (derivative) @ $0 · Conversion (C): 1,599,993 (derivative) · Conversion (C): 1,701,541 (derivative)EDGAR
2026-07-064BridgeBio Oncology Therapeutics, Inc. (BBOT)Other (J): 4,528,186 @ $0 · Other (J): 2,692,459 @ $0 · Other (J): 1,704,862 @ $0 · Other (J): 130,865 @ $0EDGAR
2026-06-184BridgeBio Oncology Therapeutics, Inc. (BBOT)Grant/award (A): 31,675 (derivative) @ $0EDGAR
2026-04-304BRIGHT MINDS BIOSCIENCES INC. (DRUG)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Sale (S): 109,331 @ $89.50EDGAR
2026-01-284/AHelix Acquisition Corp. III (HLXC)
jointly with Helix Holdings III LLC
Grant/award (A): 497,500 @ $10 · Purchase (P): 800,000 @ $10 · Other (J): 718,750 (derivative)EDGAR
2026-01-264Helix Acquisition Corp. III (HLXC)
jointly with Helix Holdings III LLC
Grant/award (A): 497,500 @ $10 · Other (J): 718,750 (derivative)EDGAR
2025-12-154Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Sale (S): 30,029 @ $11.46EDGAR
2025-12-084EyePoint, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Sale (S): 60,000 @ $15.70EDGAR
2025-10-014MoonLake Immunotherapeutics (MLTX)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP
Sale (S): 70,748 @ $9.38 · Sale (S): 232,460 @ $8.40 · Sale (S): 3,390,943 @ $7.58 · Sale (S): 2,800,000 @ $6.61 · Sale (S): 5,827 @ $6.96EDGAR
2025-08-134BridgeBio Oncology Therapeutics, Inc. (BBOT)Option exercise (M): 4,172,126 · Disposition to issuer (D): 152,940 @ $0 · Grant/award (A): 760,496 @ $10.72 · Grant/award (A): 639,110 @ $10.72 · Grant/award (A): 5,598,425 @ $10.72 · Grant/award (A): 1,905,046 · +4 moreEDGAR
2025-08-014Biomea Fusion, Inc. (BMEA)
jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Holdings only — no transactions reportedEDGAR
2025-06-134Biomea Fusion, Inc. (BMEA)
jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 91,970 (derivative) @ $0EDGAR
2025-05-194OnKure Therapeutics, Inc. (OKUR)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP
Sale (S): 1,813,439 @ $1.85EDGAR
2025-05-144OnKure Therapeutics, Inc. (OKUR)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP
Sale (S): 24,300 @ $1.99EDGAR
2025-02-194Aardvark Therapeutics, Inc. (AARD)
jointly with Cormorant Asset Management, LP
Conversion (C): 800,189 · Purchase (P): 187,500 @ $16 · Conversion (C): 6,780,810 (derivative)EDGAR
2025-02-104Helix Acquisition Corp. II (HLXB)Other (J): 30,000 (derivative) @ $0EDGAR
2024-11-064BRIGHT MINDS BIOSCIENCES INC. (DRUG)
jointly with Cormorant Asset Management, LP
Purchase (P): 184,331 @ $21.70EDGAR
2024-10-174BRIGHT MINDS BIOSCIENCES INC. (DRUG)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 238,097 @ $4.53 · Purchase (P): 63,173 @ $5.92 · Purchase (P): 33,343 @ $6.42 · Purchase (P): 8,900 @ $7.31 · Purchase (P): 2,600 @ $8.80 · Purchase (P): 2,700 @ $9.26 · +5 moreEDGAR
2024-10-014BioAge Labs, Inc. (BIOA)
jointly with Cormorant Asset Management, LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Fund IV LP
Conversion (C): 1,179,529 · Purchase (P): 450,000 @ $18 · Conversion (C): 5,263,772 (derivative)EDGAR
2024-09-244Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 45,085 @ $17.48 · Purchase (P): 25,943 @ $18.36 · Purchase (P): 66,088 @ $19.61 · Purchase (P): 139,551 @ $20.42 · Purchase (P): 47,564 @ $21.47 · Purchase (P): 25,769 @ $22.23EDGAR
2024-06-134Biomea Fusion, Inc. (BMEA)
jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 51,025 (derivative) @ $0EDGAR
2024-05-084EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 642,847 @ $11.70 · Purchase (P): 207,153 @ $12.36EDGAR
2024-04-224EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 395,244 @ $17.62 · Purchase (P): 186,521 @ $18.90EDGAR
2024-04-034Immuneering Corp (IMRX)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP
Sale (S): 100 @ $3.07 · Sale (S): 300 @ $3.06 · Sale (S): 100 @ $3.05 · Sale (S): 600 @ $3.03 · Sale (S): 10 @ $3.01 · Sale (S): 10 @ $2.98 · +2 moreEDGAR
2024-03-184Immuneering Corp (IMRX)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP
Sale (S): 345,266 @ $3.23 · Sale (S): 98,570 @ $4.25 · Sale (S): 54,215 @ $5.37 · Sale (S): 11,040 @ $5.97 · Sale (S): 400,000 @ $2.14EDGAR
2024-03-114Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 46,799 @ $37.82 · Purchase (P): 10,736 @ $39.13 · Purchase (P): 90,325 @ $39.99 · Purchase (P): 102,140 @ $41.23 · Purchase (P): 29,342 @ $41.23 · Purchase (P): 24,983 @ $42.25 · +4 moreEDGAR
2024-02-134Helix Acquisition Corp. II (HLXB)Grant/award (A): 509,000 @ $10 · Purchase (P): 69,360 @ $10 · Purchase (P): 1,427,040 @ $10 · Purchase (P): 903,600 @ $10EDGAR
2024-02-064Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 750,000 @ $19EDGAR
2024-01-304Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 14,388 @ $25.73 · Purchase (P): 15,243 @ $26.66 · Purchase (P): 36,747 @ $27.70 · Purchase (P): 31,028 @ $28.82 · Purchase (P): 29,244 @ $29.42 · Purchase (P): 2,654 @ $31 · +8 moreEDGAR
2024-01-114EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 105,000 @ $21.32 · Purchase (P): 750,000 @ $19.75EDGAR
2023-12-124EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 588,235 @ $17EDGAR
2023-12-064EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP
Purchase (P): 321,259 @ $18.80 · Purchase (P): 945,664 @ $19.88 · Purchase (P): 122,625 @ $20.62 · Purchase (P): 79,805 @ $21.87 · Purchase (P): 28,090 @ $22.80 · Purchase (P): 37,081 @ $24.01 · +11 moreEDGAR
2023-10-254Ambrx Biopharma, Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP
Purchase (P): 1,307,311 @ $6.99EDGAR
2023-10-104MoonLake Immunotherapeutics (MLTX)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP
Purchase (P): 58,839 @ $59.90EDGAR
2023-10-044MoonLake Immunotherapeutics (MLTX)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP
Purchase (P): 74,911 @ $57.37 · Purchase (P): 150,487 @ $57.25 · Purchase (P): 67,814 @ $57.32EDGAR
2023-09-194Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP
Purchase (P): 1,401,505 @ $9.05 · Purchase (P): 751,233 @ $9.24EDGAR
2023-07-244GreenLight Biosciences Holdings, PBC (GRNA)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP
Sale (S): 9,188,659 @ $0EDGAR
2023-07-054MoonLake Immunotherapeutics (MLTX)Purchase (P): 800,000 @ $50EDGAR
2023-06-284MoonLake Immunotherapeutics (MLTX)Purchase (P): 1,481 @ $36.91 · Purchase (P): 3,755 @ $38.18 · Purchase (P): 10,593 @ $39.17 · Purchase (P): 38,623 @ $39.87 · Purchase (P): 50,642 @ $41.03 · Purchase (P): 61,042 @ $42.12 · +21 moreEDGAR
2023-06-264Erasca, Inc. (ERAS)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP
Grant/award (A): 60,000 (derivative) @ $0EDGAR
2023-06-164Biomea Fusion, Inc. (BMEA)
jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 6,989 (derivative) @ $0EDGAR
2023-04-204Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP
Purchase (P): 3,376,646 @ $11.27 · Purchase (P): 951,909 @ $11.15 · Purchase (P): 886,634 @ $11.60EDGAR
2023-04-174Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP
Purchase (P): 1,193,808 @ $9.16 · Purchase (P): 841,967 @ $9.96 · Purchase (P): 562,121 @ $10.67EDGAR
2023-04-034Biomea Fusion, Inc. (BMEA)
jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Purchase (P): 400,000 @ $30EDGAR
2023-03-224MoonLake Immunotherapeutics (MLTX)Purchase (P): 446,881 @ $19.36 · Purchase (P): 63,700 @ $20.42 · Purchase (P): 78,008 @ $21.08 · Purchase (P): 238,511 @ $21.70EDGAR
2023-03-164Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP
Purchase (P): 250,000 @ $9.95 · Purchase (P): 250,000 @ $10.60 · Purchase (P): 500,000 @ $10.15EDGAR
2022-12-214/AErasca, Inc. (ERAS)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP
Purchase (P): 307,692 @ $6.50EDGAR
2022-12-204Erasca, Inc. (ERAS)
jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP
Purchase (P): 307,692 @ $6.50EDGAR
2022-06-244Biomea Fusion, Inc. (BMEA)
jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 23,867 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1599214 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs